je.st
news
Tag: oncology
J&J Study Data Shows Benefits of Oat in Skin Care for Oncology Patients
2021-04-26 14:53:28| Happi Breaking News
Daily regimen showed improvements in xerosis and pruritus.
Varian Medical Systems ARIA Oncology Information System and Eclipse Treatment Planning Software Named 2015/2016 Category Leaders in the 2015/2016 Best in KLAS: Software and Services Report
2016-02-22 11:31:13| Industrial Newsroom - All News for Today
Independent report based on customer surveys gives ARIA and Eclipse top rankings PALO ALTO, Calif. Varian Medical Systems (NYSE: VAR) today announced its ARIA oncology information system and Eclipse treatment planning software have been named "2015/2016 Category Leader" in the "Best in KLAS: Software and...
Tags: information
services
system
software
Crown Bioscience To Hold Symposium On Precision Medicine And Translating Oncology Drug Discovery Into Success In The Clinic
2016-02-02 03:04:21| drugdiscoveryonline Home Page
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, will be hosting a symposium at The Nucleus in Chesterford Research Park, UK, on Feb. 10, 2016
Tags: the
hold
success
medicine
Medidata's Risk-Based Monitoring Solution Selected By Infinity Pharmaceuticals To Advance Oncology Research
2015-11-25 01:19:03| drugdiscoveryonline Home Page
Medidata, the leading global provider of cloud-based solutions for clinical research in life sciences, recently announced that Infinity Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the discovery, development and delivery of medicines for difficult-totreat diseases, has expanded its use of the Medidata Clinical Cloud.
Tags: research
selected
solution
advance
Tyme Technologies, Inc. Receives FDA Acceptance Of Investigational New Drug Application For Oncology Drug Candidate, SM-88
2015-11-03 04:55:30| drugdiscoveryonline News Articles
Tyme Technologies, Inc., a research and development company operating through its wholly-owned subsidiary, Tyme Inc., focused on development and eventual commercialization of oncology products, announced recently that the U.S
Tags: application
drug
technologies
acceptance